CL Educate [CLEDUCATE] vs Aptech Limited [APTECHT] Detailed Stock Comparison
CL Educate
NSE
Loading...
Aptech Limited
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CL Educate wins in 8 metrics, Aptech Limited wins in 11 metrics, with 0 ties. Aptech Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CL Educate | Aptech Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 73.85 | 35.67 | Aptech Limited |
| Price-to-Book Ratio | 2.17 | 2.96 | CL Educate |
| Debt-to-Equity Ratio | 97.87 | 2.69 | Aptech Limited |
| PEG Ratio | -0.39 | 1.07 | CL Educate |
| EV/EBITDA | 20.63 | 17.79 | Aptech Limited |
| Profit Margin (TTM) | -4.72% | 4.36% | Aptech Limited |
| Operating Margin (TTM) | 6.02% | 4.40% | CL Educate |
| EBITDA Margin (TTM) | 6.02% | 4.40% | CL Educate |
| Return on Equity | -4.17% | 7.59% | Aptech Limited |
| Return on Assets (TTM) | -1.25% | 4.89% | Aptech Limited |
| Free Cash Flow (TTM) | $-141.47M | $129.04M | Aptech Limited |
| Dividend Yield | N/A | 2.95% | N/A |
| 1-Year Return | 30.85% | -40.32% | CL Educate |
| Price-to-Sales Ratio (TTM) | 1.34 | 1.56 | CL Educate |
| Enterprise Value | $5.98B | $5.37B | CL Educate |
| EV/Revenue Ratio | 1.46 | 1.13 | Aptech Limited |
| Gross Profit Margin (TTM) | 29.00% | 84.59% | Aptech Limited |
| Revenue per Share (TTM) | $77 | $82 | Aptech Limited |
| Earnings per Share (Diluted) | $-1.87 | $3.58 | Aptech Limited |
| Beta (Stock Volatility) | -0.44 | 0.17 | CL Educate |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CL Educate vs Aptech Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CL Educate | 4.17% | 24.30% | 4.57% | 8.83% | 11.31% | -11.88% |
| Aptech Limited | 0.76% | -0.07% | -11.77% | -24.65% | 0.74% | -29.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CL Educate | 30.85% | -37.01% | 325.55% | -47.56% | -47.56% | -47.56% |
| Aptech Limited | -40.32% | -44.26% | -2.18% | 100.17% | -20.41% | 45.54% |
Performance & Financial Health Analysis: CL Educate vs Aptech Limited
| Metric | CLEDUCATE | APTECHT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.50B | ₹7.43B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 197,251 | 33,679 |
| 90 Day Avg. Volume | 89,733 | 61,388 |
| Last Close | ₹105.50 | ₹128.68 |
| 52 Week Range | ₹67.50 - ₹136.98 | ₹107.00 - ₹254.00 |
| % from 52W High | -22.98% | -49.34% |
| All-Time High | ₹237.48 (Apr 17, 2017) | ₹591.95 (May 29, 2023) |
| % from All-Time High | -55.58% | -78.26% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.55% | 0.15% |
| Quarterly Earnings Growth | 0.55% | 0.33% |
| Financial Health | ||
| Profit Margin (TTM) | -0.05% | 0.04% |
| Operating Margin (TTM) | 0.06% | 0.04% |
| Return on Equity (TTM) | -0.04% | 0.08% |
| Debt to Equity (MRQ) | 97.87 | 2.69 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹46.77 | ₹43.21 |
| Cash per Share (MRQ) | ₹41.42 | ₹36.31 |
| Operating Cash Flow (TTM) | ₹-206,582,000 | ₹160.46M |
| Levered Free Cash Flow (TTM) | ₹-112,485,000 | ₹190.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.95% |
| Last 12-Month Dividend | ₹0.00 | ₹4.50 |
Valuation & Enterprise Metrics Analysis: CL Educate vs Aptech Limited
| Metric | CLEDUCATE | APTECHT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 73.85 | 35.67 |
| Forward P/E | N/A | 23.52 |
| PEG Ratio | -0.39 | 1.07 |
| Price to Sales (TTM) | 1.34 | 1.56 |
| Price to Book (MRQ) | 2.17 | 2.96 |
| Market Capitalization | ||
| Market Capitalization | ₹5.50B | ₹7.43B |
| Enterprise Value | ₹5.98B | ₹5.37B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.46 | 1.13 |
| Enterprise to EBITDA | 20.63 | 17.79 |
| Risk & Other Metrics | ||
| Beta | -0.44 | 0.17 |
| Book Value per Share (MRQ) | ₹46.77 | ₹43.21 |
Financial Statements Comparison: CL Educate vs Aptech Limited
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CLEDUCATE | APTECHT |
|---|---|---|
| Revenue/Sales | ₹948.81M | ₹1.19B |
| Cost of Goods Sold | ₹654.40M | ₹170.76M |
| Gross Profit | ₹294.41M | ₹1.02B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-34.15M | ₹58.39M |
| EBITDA | ₹89.22M | ₹113.78M |
| Pre-Tax Income | ₹-88.17M | ₹92.94M |
| Income Tax | ₹-24.33M | ₹43.50M |
| Net Income (Profit) | ₹-157.21M | ₹49.44M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CLEDUCATE | APTECHT |
|---|---|---|
| Cash & Equivalents | ₹255.41M | ₹253.38M |
| Total Current Assets | ₹4.68B | ₹3.13B |
| Total Current Liabilities | ₹2.24B | ₹1.31B |
| Long-Term Debt | ₹1.89B | ₹50.41M |
| Total Shareholders Equity | ₹2.69B | ₹2.51B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹303.73M | ₹186.60M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CLEDUCATE | APTECHT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CLEDUCATE | APTECHT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 197,251 | 33,679 |
| Average Daily Volume (90 Day) | 89,733 | 61,388 |
| Shares Outstanding | 54.10M | 58.00M |
| Float Shares | 19.17M | 21.97M |
| % Held by Insiders | 0.64% | 0.53% |
| % Held by Institutions | 0.05% | 0.02% |
Dividend Analysis & Yield Comparison: CL Educate vs Aptech Limited
| Metric | CLEDUCATE | APTECHT |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹4.50 |
| Last 12-Month Dividend Yield | N/A | 2.95% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹4.02 |
| 3-Year Avg Dividend Yield | N/A | 1.76% |
| 3-Year Total Dividends | ₹0.00 | ₹12.06 |
| Ex-Dividend Date | N/A | May 16, 2025 |